Results 121 to 130 of about 1,482 (173)

Possible Involvement of Skin-Resident Memory T Cells in Refractory Chronic Alopecia Areata. [PDF]

Exp Dermatol
Kageyama R, Ito T, Kurihara K, Fujiyama T, Honda T.   +4 more
europepmc   +1 more source

Efficacy and Safety of Ritlecitinib in the Asian Subpopulation of the ALLEGRO-2b/3 and ALLEGRO-LT Clinical Studies for Alopecia Areata. [PDF]

J Dermatol
Ueki R, Mizuashi M, Harada K, Zhang X, Wu W, Chung WH, Kwon O, Luo X, Basey V, Wolk R, Shi N, Fujita K, Shen Y, Hirose T.   +13 more
europepmc   +1 more source

Importance of alexithymia on anxiety and depression in alopecia areata: a cohort study. [PDF]

Skin Health Dis
Fhager J, Örmon K, Svensson Å, Sjöström K.   +3 more
europepmc   +1 more source

Successful Treatment of Crohn Disease and Concomitant Alopecia Totalis with Upadacitinib: Case Report and Systematic Review of the Literature. [PDF]

Acta Derm Venereol
Andersen YMF, Seyed-Alinaghi F, Kristiansen MF, Thomsen SF.   +3 more
europepmc   +1 more source

Genetic syndromes in paediatric alopecia areata: a systematic review. [PDF]

Skin Health Dis
Park M, Price E, Sibbald C.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Latanoprost in the treatment of eyelash alopecia in alopecia areata universalis

Journal of the European Academy of Dermatology and Venereology, 2010
AbstractObjectives  The aim of this study was to test the efficacy of latanoprost in eyelash alopecia areata (AA).Design  This study is a 2‐year prospective, non‐blinded, non‐randomized, bilateral eyelash alopecia controlled study.Setting  The setting of this study was Trichology Unit, Virgen Macarena University Hospital, Seville, Spain.Patients  We ...
I M, Coronel-Pérez, E M, Rodríguez-Rey, F M, Camacho-Martínez   +2 more
exaly   +3 more sources

Tofacitinib in Pediatric Alopecia Areata Totalis and Alopecia Universalis: A Retrospective Analysis From India

Journal of Cutaneous Medicine and Surgery
Alopecia areata totalis and universalis are disabling conditions and therapeutically challenging as they are refractory to conventional options. Tofacitinib is a Janus-kinase (JAK) inhibitor utilized to treat alopecia areata (AA) as an off-label drug. In India, FDA-approved JAK inhibitors such as baricitinib and ritlecitinib are not available.
Akash Agarwal, Pavithra A, Biswanath Behera   +2 more
exaly   +3 more sources

EFFECT OF A.C.T.H. ON HAIR GROWTH IN ALOPECIA AREATA AND UNIVERSALIS

Lancet, The, 1952
exaly   +3 more sources